Private equity firms are Instil Bio, Inc.'s (NASDAQ:TIL) biggest owners and were rewarded after market cap rose by US$52m last week [Yahoo! Finance]
Instil Bio, Inc. (TIL)
NASDAQ:AMEX Investor Relations:
nasdaq.com/symbol/til
Company Research
Source: Yahoo! Finance
51% of the business is held by the top 4 shareholders Institutional ownership in Instil Bio is 17% Every investor in Instil Bio, Inc. ( NASDAQ:TIL ) should be aware of the most powerful shareholder groups. We can see that private equity firms own the lion's share in the company with 39% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Clearly, private equity firms benefitted the most after the company's market cap rose by US$52m last week. In the chart below, we zoom in on the different ownership groups of Instil Bio. View our latest analysis for Instil Bio What Does The Institutional Ownership Tell Us About Instil Bio? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. We can see that Instil Bio does have institutional investors; and they hold a good portion of the compa
Show less
Read more
Impact Snapshot
Event Time:
TIL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TIL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TIL alerts
High impacting Instil Bio, Inc. news events
Weekly update
A roundup of the hottest topics
TIL
News
- Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast CancerGlobeNewswire
- Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? [Yahoo! Finance]Yahoo! Finance
- Summit boosts Instil, BioNTech as lead drug beats Merck's Keytruda [Seeking Alpha]Seeking Alpha
- Futures Gain As Expectations For A 50bps Rate Cut Spike [zero hedge]zero hedge
- Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewswire
TIL
Earnings
- 8/13/24 - Beat
TIL
Sec Filings
- 10/25/24 - Form SC
- 10/22/24 - Form SC
- 9/27/24 - Form SC
- TIL's page on the SEC website